Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CERENOVUS
Irvine, California, United States
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
CERENOVUS, now part of Johnson & Johnson MedTech, offers FDA-approved and CE-marked neurovascular devices including stent retrievers, catheters, detachable coils, and embolic agents used in the endovascular treatment of ischemic and hemorrhagic stroke, with recent expansion in minimally invasive liquid embolic systems. Interim registry (EXCELLENT) data supports product use in real-world neurointerventional settings.[1][3]
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Device
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on CERENOVUS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CERENOVUS.